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Solid stress and elastic energy as measures of
tumour mechanopathology
Hadi T. Nia1, Hao Liu1,2 , Giorgio Seano1, Meenal Datta1,3 , Dennis Jones1, Nuh Rahbari1, Joao Incio1,4 ,
Vikash P. Chauhan1, Keehoon Jung1, John D. Martin1, Vasileios Askoxylakis1, Timothy P. Padera1,
Dai Fukumura1, Yves Boucher1, Francis J. Hornicek5, Alan J. Grodzinsky6, James W. Baish7,
Lance L. Munn1 and Rakesh K. Jain1*
Solid stress and tissue stiffness affect tumour growth, invasion, metastasis and treatment. Unlike stiffness, which can be
precisely mapped in tumours, the measurement of solid stresses is challenging. Here, we show that 2D spatial maps of the
solid stress and the resulting elastic energy in excised or in situ tumours with arbitrary shapes and a wide range of sizes can
be obtained via three distinct and quantitative techniques that rely on the measurement of tissue displacement after disruption of the confining structures. Application of these methods in models of primary tumours and metastasis revealed that
(i) solid stress depends on both cancer cells and their microenvironments, (ii) solid stress increases with tumour size and
(iii) mechanical confinement by the surrounding tissue substantially contributes to intratumoral solid stress. Further study
of the genesis and consequences of solid stress, facilitated by the engineering principles presented here, may lead to new
discoveries and therapies.

I

ncreased tissue stiffness is a widely accepted and actively studied
biomechanical property of fibrotic tumours and has been linked
to several hallmarks of cancer, including growth, metabolism,
invasion and metastasis1–7. However, the abnormal mechanics of
tumours are not limited to tissue stiffening. We recently demonstrated that solid stress represents a new mechanopathology that is
consistently elevated in mouse and human tumours8,9. Solid stress
is distinct from interstitial fluid pressure, as the former is contained
in—and transmitted by—solid and elastic elements of the extracellular matrix and cells rather than fluids10. Therefore, tumours are
not only more rigid than many normal tissues, but cancer cells also
produce and are exposed to these physical forces. Composed of a
combination of tension and compression, these forces are significant in tumours, but negligible in most normal tissues.
Early evidence for the existence of solid stress in tumours
came from the discovery that blood and lymphatic vessels are
mechanically compressed11–13. This can contribute to hypoxia9,14,
promote tumour progression and decrease the efficacy of chemo-,
radio- and immunotherapies15. In addition to these physiological
consequences, forces can directly affect tumour biology: the exogenous application of solid stress in vivo can mechanically stimulate
tumorigenic pathways, increasing β
-catenin signalling in colon
epithelia16, and the controlled application of compressive forces
in vitro affects the growth8 of cancer cells and promotes their collective migration17. Strategies designed to reduce solid stress and
decompress blood vessels by reducing levels of collagen and hyaluronic acid14,18,19 have led to therapeutic approaches for enhancing
the efficiency of conventional anticancer treatments and are currently being tested in clinical trials20,21.

Despite the important implications of solid stress and the
immense potential for finding new mechanically activated pathways and targets, there are currently no high-resolution methods
for quantifying solid stress in experimental or human tumours.
Unlike stiffness, which can be measured using widely available multiscale techniques, measuring solid stress in biological tissues has
proved challenging. Previous studies in our laboratory8,9, based on
previous observations22,23 that arterial wall tissue relaxes if the contained forces are surgically released, demonstrated the presence of
residual tissue stresses in tumours. However, this approach is based
on a partial cut through a spherical model of the tumour, which
makes the precise release of solid stress and the measurement of
the ensuing deformation challenging. This method is also limited to
bulk estimation of solid stress and is not applicable in situ. The optical-depth limitations of alternative imaging-based methods, such as
fluorescent oil microdroplet injection24 and single-molecule fluorescent force sensors25, restrict their use to cellular- and subcellularscale force detection.
We have developed experimental and mathematical frameworks to provide 2D mapping of solid stress in tumours (planar-cut
method), sensitive estimations of the solid stress in small tumours
with small magnitudes of solid stress, as is the case for metastatic
lesions (slicing method), and in situ quantification of solid stress in
tumours, which retains the effects of the normal surrounding tissues
(needle-biopsy method). All three methods are based on the concept of releasing the solid stress in a controlled way with a defined
geometry and then quantifying the stress-induced deformation
via high-resolution ultrasonography or optical microscopy. Given
the specific topography of the stress relaxation and the geometric
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and material properties of the tumour, solid stress and discharged elastic energy are estimated using mathematical modelling. Applying these methods to multiple mouse cancer models in
primary and metastatic settings has led to the following findings:
(i) solid stress and elastic energy may differ between primary and
metastatic settings, as they depend on both cancer-cell type and
their microenvironment; (ii) tumours with higher elastic energy
are not necessarily stiffer, and the stiffer tumours do not necessarily
have higher elastic energy; (iii) solid stress increases with tumour
size; and (iv) the normal tissue surrounding a tumour substantially
contributes to intratumoral solid stress.

2D mapping of the solid stress

To produce a 2D map of the solid stress, we made a clean cut through
freshly excised tumours embedded in 2% agarose (Fig. 1a). The planar cut removes the mechanical confinement at the cut surface and
allows this face of the tumour to deform accordingly, as previously
predicted by our mathematical model9. The deformation is a measure of the stored elastic energy in the tissue caused by solid stress
(Fig. 1b). The deformation in the z direction, uz(x,y), imaged over the
x–y cross-section of the tumour, is an indicator of the magnitude and
direction of the solid stress in the z direction at the incision plane:
regions with positive deformation (bulged) were under compression
and regions with negative deformation (depressed) were under tension (Fig. 1a,b). For tissues with negligible solid stress, such as normal kidney and liver tissues, deformation was negligible and uniform
across the incision surface (Fig. 1c). The deformation is spatially
mapped in 3D via high-resolution ultrasound (resolution of 30 μm).
By developing a mathematical model (a 3D finite-element model;
Fig. 1b), the 2D map of deformation uz is converted to the strain tensor εij = 1 / 2(∂u i / ∂x j + ∂u j / ∂x i ), from which the stress tensor σij is
estimated on the basis of Hooke’s law26, written in index notation as
σij =


v
E 
εkkδ ij 
εij +

(1 + v ) 
(1 + 2v )

(1)

where E is Young’s modulus (stiffness), v is Poisson’s ratio of the tissue (assuming linear isotropicity) and δij is the Kroenecker delta. We
used the average Young’s modulus of the tumour, measured via an
unconfined compression test at the macroscale or via atomic force
microscopy measurements at multiple indentation sites. However,
the finite-element model is capable of incorporating the previously
reported 3D stiffness heterogeneities of the tumour27,28. Since the
cut fully releases the stress component σzz at the cut plane, we report
only this stress component at the cut surface throughout this study.
The other stress components, such as the stresses in the x–y plane,
are also affected and accounted for in the 3D model. However, since
the planar-cut method does not fully release these stresses, we do
not report them in this study.
Similar to a spring that is compressed (Fig. 1b), the solid-stress
field does mechanical work as it accumulates in the tumour; this
work is stored as elastic potential energy during tumour growth.
The elastic energy density, W, released by the incision is calculated
from the following equation26 for a tumour half with volume V:
W=

1
2V

∫V σijεij dV

(2)

Although W is averaged over the volume of the tumour hemisphere, it is not equivalent to the total elastic energy of the tumour.
The elastic energy W is only the energy that is released from the
relaxation of the solid stress at the desired cut plane; for the locations far from the cut plane, the elastic energy and solid stress
are not fully released. To enable an estimation of the total elastic
energy in a tumour, it would need to be cut into infinitesimally
2

small pieces to release all of the solid stress and elastic energy.
The elastic energy is not independent of solid stress; however,
it describes the tensor-based stress field more sensitively and in
the form of a single scalar quantity. Furthermore, elastic energy
rigorously differentiates between the forces emanating from the
solid versus fluid phases1 of the tumour on the basis of the following
considerations: (i) the interstitial fluid is incompressible, so the
fluid pressure cannot do work on the fluid phase of the tumour; and
(ii) the solid phase is porous and fluid can flow through it, so the
fluid pressure cannot do work on the solid phase of the tumour in
quasi-equilibrium events, such as tumour growth.
Using the planar-cut method, we mapped solid stress for three
mouse models of orthotopically implanted primary tumours: breast
(adenocarcinoma, MMTV-M3C), pancreatic (pancreatic ductal
adenocarcinoma (PDAC), AK4.4) and brain (glioblastoma, U87)
(Fig. 1d). For each model, a representative ultrasound image shows
the stress-induced deformation quantified with respect to the cut
plane (yellow dashed lines). The 2D deformations obtained via quantification of δz based on the reference incision plane from ultrasound
images, the 2D map of the solid stress σzz, estimated from the finiteelement model, and the profile of σzz across the bisecting dashed lines
are shown in the lower panels. The 2D maps of σzz in the breast and
pancreatic tumours show a common pattern of compressive stresses
in the central regions, and tensile stresses with higher magnitude
in narrow peripheral regions. However, in the U87 model of glioblastoma, the tumour experiences compressive stresses over annular regions close to the periphery, rather than in the centre of the
tumour. The maximum value of the solid stress varies from 0.21 kPa
(1.56 mmHg) in brain tumours to 7 kPa (52.5 mmHg) in pancreatic
tumours (which are highly desmoplastic). The planar-cut method is
capable of estimating a large dynamic range of solid stresses in addition to the variation in the pattern of the compressive and tensile
stresses stored in different tumour types. We also demonstrated the
planar-cut method on human chondrosarcoma tumours, for which
the 2D deformation maps are shown in Supplementary Fig. 1.
We hypothesized that structural elements such as collagen fibres
are critical to transmitting solid stress9,14. To test this hypothesis,
we enzymatically depleted collagen in the MMTV-M3C model of
breast cancer using a collagenase treatment ex vivo. We showed that
the average magnitude of the solid stress <|σzz|>was reduced by a
factor of more than two, whereas the elastic energy density W was
reduced by a factor of more than six (Fig. 1e).

The microenvironment influences solid stress

Little is known about how biomechanical abnormalities vary
between primary and metastatic lesions or how these differences
affect tumour biology. To address this, we used the planar-cut
method to estimate and compare the solid stress, elastic energy
and mechanical stiffness in size-matched tumours formed from the
same cell lines, and in primary versus metastatic sites.
We found that primary PDAC AK4.4 tumours had much higher
levels of solid stress than PDAC liver metastases (Fig. 2a,b), despite
the fact that both tumours were formed by the same cell line and
were approximately size matched. Since these two tumours have
similar elastic moduli (Fig. 2e), the higher deformation after incision
results in higher stress values (Fig. 2f) and higher elastic energies
(Fig. 2g) in primary sites than in liver metastases. This comparison shows that AK4.4 tumours growing in the pancreas generate a
higher solid stress and store more elastic energy than AK4.4 liver
metastases. Interestingly, this trend is reversed in colorectal carcinomas (Fig. 2c,d): the primary colorectal tumours have lower levels of
solid stress and elastic energy than colorectal cancer liver metastases,
despite having similar elastic moduli. Our data show that the growth
in the liver microenvironment does not always result in lower stored
elastic energy. An interesting comparison can also be made between
metastases of different cancer cells in the same host organ (in this

nature Biomedical engineering 1, 0004 (2016) | DOI: 10.1038/s41551-016-0004 | www.nature.com/natbiomedeng

Articles

Nature Biomedical Engineering
a

b

High-resolution
ultrasound probe

Agarose gel
embedding the tumour

Stress-induced
deformation u

Cut plane, a reference for
deformation measurement

Stored elastic
energy, W

z
x
y

Before stress relaxation

c
Ultrasound image

Normal kidney

Cut plane

d

Stiffness, E
uz (x,y)

Stressed

Stress-released

After stress relaxation
Pancreatic tumour (AK4.4)

Breast tumour (MMTV-M3C)

Brain tumour (U87)

Cut plane

Tumour
Brain

0.3

0.3

0.6

0.0

0.0

0.2

–0.3

–0.2

–0.3
Depressed

Normal liver

2 mm

Control

2 mm
Solid stress zz (kPa) Solid stress zz (kPa)

2 mm

2 mm

Tensile
+1.04
+0.75
+0.58
+0.38
+0.19
−0.00
−0.30
Compressive
1.00
0.75 Tensile
0.50
0.25
0.00
–0.25 Compressive
0
2
4
Position (mm)

6

6
4
2
0
–2
–4

0

2

4
6
8
Position (mm)
Control

Solid stress <|zz|> (kPa)

+0.50
+0.39
+0.28
+0.17
+0.07
−0.04
−0.15

Solid stress zz (kPa)

3 mm

0.04

10

0.6
0.3
0.0

2 mm
Brain

0.15
0.10
0.05
0.00
–0.05
–0.10

+0.21
+0.13
+0.09
+0.04
−0.01
−0.06
−0.10

Tumour

0

2

4
6
Position (mm)

8

Collagenase-treated
5.0

*

0.08
0.06

Tumour

+7.50
+5.62
+3.77
+1.85
–0.03
–1.92
–3.80

Collagenase-treated
0.10

Brain

1.0

0.6

*

4.0
W (J m–3)

Deformation
uz (mm)

Bulged
0.6

e

Strain ij
after relaxation

Solid stress ij

3.0
2.0

0.02

1.0

0.00

0.0

Figure 1 | 2D maps of solid stress in tumours. a, The fresh tumour was embedded in 2% agarose (liquid at 40 °C), and then gellated in ice water.
The tumour–agarose construct was incised at the plane of interest to release solid stress. The release of solid stress resulted in a deformation field
δz(x,y) with respect to the agarose reference plane; δz and the tumour geometry were quantified via high-resolution ultrasound (resolution of 20 μm).
b, Using a finite-element model, σzz, the mechanical stress in the z direction, and W, the elastic energy stored by solid stress, were estimated from
the deformation δz and Young’s modulus of the tissue on the basis of Hooke’s law. c, The stress-induced deformation δz was uniform and negligible in
stress-free normal tissues (for example, kidney (top) and liver (bottom)). d, Representative ultrasound images showing the stress-induced deformation and
agarose reference line (yellow dashed line), 2D deformation fields δz, 2D stress fields σzz, and representative stress profiles across the tumour diameter,
all for mouse models of breast tumour (MMTV-M3C), pancreatic ductal adenocarcinoma tumour (AK4.4) and brain tumour (glioblastoma, U87).
e, Enzymatic depletion of collagen in a (MMTV-M3C) breast tumour resulted in notable reduction of solid stress and elastic energy density (control,
n =5 mice; collagenase-treated, n =4 mice; mean ±standard error of the mean; *P <0.05). A representative ultrasound image and a solid-stress map are
shown for the control and collagenase-treated tumours.
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Figure 2 | Solid stress and elastic energy in primary versus metastatic tumours. a–d, Representative ultrasound images and 2D stress maps are shown for
size-matched primary pancreatic ductal adenocarcinoma (PDAC, AK4.4; n =4 mice) (a), liver metastasis of PDAC (AK4.4; n =3 mice) (b), primary colorectal
carcinoma (SL4; n =3 mice) (c) and liver metastasis of colorectal carcinoma (SL4; n =4 mice) (d). e–g, Comparison of Young’s modulus (unconfined
compression) (e), average solid stress in the z direction, σzz (f) and elastic energy density (g) in these four tumour models shows that the type of cancer cell
is not the only determinant of biomechanical abnormalities: the organ and microenvironment in which the cancer cells reside are equally important in the
generation of solid stress and elastic energy in tumours. The data shown are mean ±the standard error of the mean; n.s., not significant; *P < 0.05.

case, the liver). Although the elastic modulus of PDAC liver metastases is fivefold larger than that of the colorectal cancer liver metastases, the elastic energy actually shows the opposite trend. This is due
to considerably larger stress-induced deformation in colorectal cancer liver metastasis and to the greater dependence of elastic energy
on stress-induced deformation (equation (2)). The solid stress
shows a trend that is lower than but similar to the trend of the elastic
modulus between the two metastases, as the solid stress follows a
linear relationship with the deformation (equation (1)). From the
above comparisons we observe that (i) solid stress and elastic energy
are mechanical abnormalities that vary between tumours; (ii) solid
stress and elastic energy depend on both the cancer-cell type and
the microenvironment in which they reside; and (iii) tumours with
greater elastic energy are not necessarily stiffer, and stiffer tumours
do not necessarily have greater elastic energy.

Tissue slices allow measurements in small tumours

To measure the solid stress and elastic energy in smaller tumours
(for example, in micro- and macro-metastases), we developed a
more sensitive method—also based on releasing elastic energy—
by slicing the tissue into thin slices (Fig. 3a). Again, the freshly
4

excised tumour is embedded in 2% agarose, which is then sliced by
a vibratome with a desired thickness in the range 100–500 μm. The
tumour slice, originally flat, undergoes expansion and contraction
in the area of the slice when the in-plane stresses and elastic energy
are released (Supplementary Fig. 2), as demonstrated in models of
breast tumours (MMTV-M3C), pancreatic tumours (PDAC, AK4.4)
and lymph-node metastasis of breast cancer (4T1) (Fig. 3b–d).
Inhomogeneities in the in-plane stresses (shown for the partial
release of these stress components in Supplementary Fig. 3) mean
that the slice undergoes out-of-plane bending and buckling. This
method is more sensitive than the planar-cut method since a thin
slice is exposed to more degrees of freedom to deform and reacts
to even small levels of solid stress. The deformed slices are then
imaged in 3D using high-resolution ultrasound (used here for AK4.4
and MMTV-M3C tumours) or optical frequency domain imaging
(OFDI; used here for lymph node metastasis)29 after stress relaxation. The compressive and tensile stresses (as mapped in Fig. 1d)
are released in different ways: the compressive forces are released
by the slice volume expanding (which results in lateral bending
and buckling) and the tensile forces are released by the periphery of the tumours pulling inwards. Thus, the complex geometry
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Investigating the accumulation of solid stress as a function of
tumour growth provides invaluable information regarding both
the genesis and the implications of solid stress. We used the slice
method to measure IER (equation (3)) induced by the relaxation of
solid stress in MMTV-M3C breast tumours, for tumours ranging in
size from 2 to 7 mm in diameter (Fig. 4a). The elastic modulus was
also measured via atomic force microscopy (AFM)-based indentation for a similar range of tumour sizes. The expansion ratio (equation (3)) induced by the relaxation of in-plane stresses in the slice
increased considerably with increasing tumour diameter (Fig. 4a,b).
Tumours with small diameters (2–3 mm) did not show a notable
increase in area after slicing, whereas the larger tumours showed an
area expansion of up to 30–40%. Notably, the AFM-based indentation modulus did not show any substantial trend with tumour diameter (Fig. 4c). This confirms that solid stress and elastic energy can
be considered as mechanical abnormalities distinct from stiffness.
The type I collagen (collagen I) network becomes more organized and more localized at the periphery with increasing tumour
size in the MMTV-M3C breast tumour model, consistent with the
increase in solid stress. As shown via immunofluorescence analysis,
the type I collagen network is uniformly and randomly distributed
in smaller tumours (diameter ~2 mm; Fig. 4d) and becomes more
localized and organized at the periphery in larger tumours (diameter ~7 mm). To quantitatively describe this collagen I localization

Undeformed
tumour slice

Ultrasound
probe
Deformed
tumour slice
Blank

(3)

where Atumour is the surface area of the tumour slice after the elastic energy is released and obtained from the 3D image of the slice,
and Ablank is the reference area of the tumour slice before slicing,
obtained from the empty space left in the agarose gel (Fig. 3h,i). The
expansion ratio has been quantified as 30.7  ±  5.8% for the breast
tumour, 34.0 ± 4.9% for the PDAC and 17.2 ± 1.2% for the lymph
node with breast cancer macro-metastasis, which are considerably higher than the control tissues: 7.0 ± 1.9% for the kidney and
5.0 ± 1.2% for the lymph node with micro-metastasis (Fig. 3j and
Supplementary Fig. 4). Note that with this method the tumour
undergoes consecutive cuts before the desired tumour slice is
obtained. In doing so, the out-of-plane stresses (σzz) are fully released,
similar to the planar-cut method. In addition, the in-plane stresses
(σxx and σyy) are also partially released, as shown in the example in
Supplementary Fig. 3. For the representative case of the MMTV-M3C
model of breast cancer, we showed that the slicing method releases
the majority of the in-plane stresses compared with the relaxation
of in-plane stresses that occurs before the slicing. The average area
strain obtained via the slicing method in the MMTV-M3C model
is IER = 30.7%, which results in <σin-plane> = 0.27 kPa (E = 0.87 kPa).
However, the average σxx and σyy released by the cuts prior to the
desired slicing are 0.069 kPa and 0.078 kPa (Supplementary Fig. 3),
respectively, no larger than one-third of <σin-plane>, which shows that
the majority of the in-plane stresses are relaxed when using the slice
method and are thus reported as area strain IER (equation (3)).
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formed from an originally flat disc-shaped slice is the result of
non-uniformity and coexisting residual tension–compression inplane stresses released in the slice. We used this method on normal
kidney and lymph node micro-metastases, and observed negligible
deformation after slicing (Fig. 3e,f), consistent with the results of the
planar-cut method (Fig. 1c).
The release of elastic energy via slicing results in the expansion
of the surface area of the slice. The overall area expansion after slicing represents the area strain, a quantitative index for in-plane solid
stresses and the stored elastic energy in the slice. We defined the
area-expansion ratio as follows:

Figure 3 | Creating tumour slices provides a sensitive measure of
the solid stress that is applicable to a wide range of specimen sizes.
a, The fresh tumour is embedded in liquid 2% agarose, then sliced with a
vibratome and left in phosphate-buffered saline (PBS) at room temperature
so that stress-induced deformation occurs in the tumour slice. The
deformed slice and the surrounding agarose disc are imaged using highresolution ultrasound (30 μm resolution) or OFDI (1 μm resolution) for
small samples (for example, lymph node). b–d, Buckling and deformation
of representative slices from breast tumour (MMTV-M3C) (b), pancreatic
tumour (AK4.4) (c) and lymph node with macro-metastasis of breast
cancer (4T1) (d). e,f, Tissues with negligible or low levels of stress, such as
lymph node with micro-metastasis (e) and kidney (f). g, The blank space
in the agarose disc represents the area of the tumour slice before the stress
relaxation. Scale bars, 1 mm. h, 3D reconstructions of the slices in breast and
pancreatic tumours compared that of with kidney tissue. i, The expansion
ratio, an index of solid stress and elastic energy, is defined as the ratio of
the surface area of the slice after stress relaxation, Atumour, to the area of the
blank space in the agarose disc, Ablank (equivalent to the area of the slice
before stress relaxation). j, The expansion ratios in breast (n =3 slices) and
pancreatic tumours (n =3 slices) are substantially higher than the expansion
in the kidney slice (n =3 slices). The expansion ratio of lymph-node macrometastasis (n =4 slices) is considerably higher than in the micro-metastatic
lymph node (n =4 slices). The error bars indicate the mean ± standard error
of the mean. PDAC, pancreatic ductal adenocarcinoma. *P < 0.05.
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Figure 4 | Evolution of solid stress and stiffness as a function of tumour size. a, Solid stress was estimated with the slicing method in breast tumours
(MMTV-M3C) with mean diameters ranging from 2 to 7 mm (representative ultrasound images shown). b, The expansion ratio—an index of solid
stress—increased substantially with increasing tumour size. c, The AFM-based indentation modulus of the same tumour model did not vary much with
tumour size. d, Top: representative immunofluorescence images of collagen I staining (white) of the MMTV-M3C tumours. Middle: the collagen content
(assessed by positively stained collagen I area fraction) became localized to the tumour periphery with increasing tumour size. Bottom: the collagen
spread radius Rc, defined as the effective normalized radius of an area that contains 50% of the positively stained collagen, increased with tumour
diameter. e, The fraction of perfused blood vessels shows a decreasing trend with increasing tumour size, consistent with the hypothesis that high
solid stress (which increases with tumour size, as shown in b) compresses blood vessels14. The data shown in b–d are mean ±the standard error of the
mean. Each data point in b represents three slices from each mouse; each tumour diameter is associated with a different mouse. In c, each data point
represents 10 indentation sites from each mouse. In d, ten radial sectors have been quantified for each data point.

effect, we defined a collagen spread radius, Rc, as the radius of an
area that contains 50% of the positively stained collagen I. This
radius increases substantially with the tumour diameter (Fig. 4d),
consistent with a similar increase in area expansion ratio (Fig. 4b).
The highly oriented collagen (Supplementary Fig. 5) with increased
density at the periphery implies that the periphery of the tumour
experiences tensile stresses. This tensile stress in the periphery, consistent with the stress map in Fig. 1d, is hypothesized to originate
from the direct contraction of carcinoma-associated fibroblasts30,31
or from the resistance to the compressive forces emanating from the
volume increase resulting from cell proliferation and extracellular
matrix deposition.
Whereas solid stress increased with tumour size, the fraction of perfused vessels showed the opposite trend (Fig. 4e; see
also Supplementary Fig. 6 for representative images), consistent
with the hypothesis that solid stress can compress blood vessels
and decrease tumour perfusion9,14,19. These data also suggest that
stiffness, which showed no notable trend with tumour growth
for the range of tumour diameters examined in this study, is not
6

a major contributor to the compression and collapse of intratumoral blood vessels.

The surrounding tissue affects tumour solid stress

So far, we have estimated the solid stress and elastic energy of
tumours ex vivo, independent of the surrounding normal tissue.
Next, via in situ estimations of solid stress, we show that the resistance to growth by the surrounding tissue also substantially contributes to the solid stress in the tumour—as previously predicted
by our mathematical model32,33. To measure in situ solid stresses, we
performed a core biopsy of the tumour to create a cylindrical void.
We call this the needle-biopsy method. The changes in the diameter of the cylindrical void, measured by ultrasonography, represent
a 1D stress profile of the tumour. We first evaluated this method
ex vivo to release the solid stress in the MMTV-M3C model of
breast tumours: the cylindrical void reduced in diameter in the
centre and increased in diameter at the periphery of the tumour
(Fig. 5b). This deformation profile indicates that there are compressive stresses in the centre and tensile stresses in the periphery
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Figure 5 | In situ measurements of solid stress. The normal tissue that surrounds the tumour substantially contributes to the state of stress inside the
tumour. a, The stress was released by punching a cylindrical void in the tumour. The stress relaxation resulted in deformation along the axis of the void:
compressive and tensile stresses contracted and enlarged the hole, respectively. The changes in the geometry of the biopsy core are also an indicator
of solid stress. b, This method is validated on breast tumour (MMTV-M3C), as shown in a representative ultrasound image. c,d, In liver (c) and kidney
(d) tissues—control tissues with negligible stored stress—the profile of the biopsy void and core remained constant. Scale bars, 2 mm. e, The punching
method is capable of in situ estimations of solid stress in tissues. The punch can release solid stress in the axis of interest without disturbing the boundary
between tumour and surrounding tissue, as schematically shown for the case of brain tumour with an intact normal brain and cranium. f, The stressinduced deformation was measured for brain tumour (glioblastoma, U87) in situ (by punching the tumour surrounded by brain through a cranial window;
n = 5) and ex vivo (by punching surgically excised tumour; n = 4). *P < 0.05. g,h, Representative ultrasound images of the stress-induced deformation and
the respective distribution of radial solid stress, σrr, the stress at the surface of the punched hole in the r direction, for the ex vivo (g) and in situ (h) cases.
The solid stress was estimated by an axisymmetric mathematical model that used the stress-induced deformation and the elastic properties of the tumour
and the brain as inputs.

of the tumour, consistent with the results obtained by the planar-cut
method (Fig. 1d). As expected, the diameter profile of the biopsy
void remained unchanged in control tissues (kidney and liver), in
which solid stress is negligible (Fig. 5c,d).
In addition to the void left by the biopsied material, the biopsy
core also contained useful information about the state of solid stress
in the probed tissue. The tip of the core shrank because of the tensile
contraction at the periphery, and the diameter in the middle region
increased because of the release of compressive stresses (Fig. 5b).
The biopsy cores from the control tissues (kidney and liver) did
not deform, again because of the negligible solid stress and elastic
energy in these tissues (Fig. 5c,d).
Next, we utilized the needle-biopsy method for in situ stress measurement and showed that the solid stress in ex vivo brain tumours
(glioblastoma, U87) is lower in magnitude and different in profile
than in tumours that are surrounded by the brain and cranium

(in situ; Fig. 5e–g). We used the same glioblastoma model (U87) for
which the 2D stress map was quantified in Fig. 1, and released the
solid stress via a biopsy punch while the tumour was still surrounded
by brain and cranium. For in situ measurements, we first made a
2-mm-diameter hole in the cranial window (Fig. 5h) through which
we accessed the tumour with a biopsy punch (1.5 mm diameter).
The biopsy void reduced in diameter at regions close to the tumour
rim, consistent with the 2D map of deformation (Fig. 1d) but in
contrast to the primary breast tumours, where the maximum deformation occurred in the centre (Fig. 5b). For ex vivo measurements,
the tumour was surgically resected from the brain and embedded
in 2% agarose; the stress was released by the same biopsy technique (Fig. 5g). We observed an overall smaller deformation for the
ex vivo tissues than for the in situ tissues, and these differences in
deformation were notable in regions closer to the outer rim of the
tumour (Fig. 5f). Using a mathematical model, the maximum radial
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stress for the in situ case was estimated as 0.1 kPa in compression
compared with 0.02 kPa in the ex vivo case.

Discussion

On the basis of the fundamental concept that tissues containing
solid stress deform after release from physical confinement, we
developed three different experimental techniques and appropriate
mathematical models to quantify solid stress and elastic potential
energy in solid tumours. The first method, based on releasing solid
stress at a plane created by bisecting the tumour, revealed the 2D
spatial distribution of solid stress. This method allowed us to distinguish regions with tensile stresses, mostly at the periphery, from
the central regions of the tumour that experience mainly compressive stresses. The second method, based on releasing solid stress by
creating thin tumour slices, provides a sensitive approach to quantifying low levels of solid stress in small specimens, such as small
metastatic lesions in mice. The third method, based on releasing
solid stress by core biopsy, is capable of both in situ and ex vivo estimations of solid stress. The in situ feature of this method allowed
the determination of the contribution of the surrounding tissue to
intratumoral solid stress. Importantly, we found that biopsy cores
also undergo ex vivo stress-induced deformation and could potentially be used for the measurement of solid stress in the clinic (see
Supplementary Table 1 for the capabilities and limitations of each
method). These methods overcome the previous technical challenges in measuring these biomechanical abnormalities.
The reliable and precise quantification of solid stress and elastic
energy has the potential to promote the discovery of new signalling
pathways and therapeutic strategies. The repurposing of losartan14,
an angiotensin receptor inhibitor, and PEGPH2018, a recombinant
hyaluronidase, in cancer therapies is partly based on releasing the
mechanical forces exerted on blood vessels in tumours by targeting
collagen I and hyaluronic acid. The administration of both drugs
increased the efficacy of chemotherapy in preclinical models, leading to two phase II clinical trials20,21. Similar to the earlier method
of estimating solid stress9, the methods developed here could also
be used to compare agents that can lower solid stress. Moreover,
characterization of solid stress would help elucidate the relationship
between obesity and the cancer immune microenvironment. As we
recently found in PDAC tumours34,35, synergies between adipocytes,
immune cells and fibroblasts lead to an exacerbated desmoplastic
microenvironment during obesity, further promoting blood vessel
compression. This is arguably the most important consequence of
solid stress demonstrated so far.
Solid stress and elastic energy can also be used as prognostic and
diagnostic markers. Factors such as tumour growth pattern and collagen architecture, both closely associated with solid stress, have
been shown to have prognostic values. Growth pattern, histologically
categorized as pushing versus replacing phenotypes, has been
linked to overall survival36 and recurrence risk37. As shown in Fig. 2,
colorectal cancer liver metastases with pushing growth patterns have
higher elastic energies than pancreatic cancer liver metastases with
replacing growth patterns (Supplementary Fig. 7). Furthermore,
collagen orientation and alignment have been shown to correlate
with prognosis in patients with breast cancer38. As shown, the collagen network in our breast tumour model becomes more organized
as the solid stress increases with tumour growth. The quantification
of solid stress and its association with growth pattern and collagen
architecture suggests that solid stresses may reveal the mechanisms
that underlie these histological patterns and lead to further prognostic biomarker discoveries.
The needle-biopsy and planar-cut methods both provide quantitative measurements of solid stress and have potential for use in
the clinic. Biopsy samples are obtained routinely during the diagnosis and treatment of cancer; as we show in Fig. 5a,b for the needlebiopsy method, the biopsy core contains useful information about
8

solid stress in tumours. The solid stress in the biopsy core could be
initially evaluated in clinical trials as a new biomarker and used to
investigate the mechanism underlying the link between solid stress,
collagen orientation and growth patterns. The planar-cut method
currently requires the sample to be embedded in agarose and imaged
via high-resolution ultrasound; clinically, this procedure may affect
the routine processing of tumours by pathologists. To facilitate this
procedure, we are working with pathologists to develop methods
of generating 3D reconstructions of stress-induced deformation of
patient specimens utilizing laser scanning technologies. This methodology will eliminate the agarose-embedding step, shorten the
imaging time and provide the strain field in a larger field of view
in the tumour and its surrounding tissue; it could be coupled with
routine pathological processes on freshly excised tumours. Using
fiducial markers, solid stress maps would be matched and compared with histological images from the same cut plane. We expect
that clinically accessible and quantitative measurement of solid
stress and elastic energy will provide new prognostic and diagnostic markers, similar to those provided by stiffness39,40 and interstitial fluid pressure41–43, two mechanical abnormalities that have been
used as prognostic biomarkers.
Finally, we used the above methods to demonstrate that elevated solid stress and stiffness are two distinct biomechanical
abnormalities. This important distinction implies that attempts
to normalize the tumour’s mechanical environment should not be
limited to decreasing the stiffness. Two of our independent (but
consistent) findings demonstrate that (i) primary and metastatic
tumours can have substantially different levels of solid stress despite
similar stiffness values (Fig. 2e,g) and (ii) solid stress increases with
tumour growth, even though stiffness did not change in our tumour
models (Fig. 4b,c). These results clearly suggest that the external
compressive or tensile solid stresses of tumour cells may be independent of the cellular focal-adhesion forces that are generated in
response to changes in the stiffness of the matrix in their vicinity.
With the methods and results shown here, we now have the tools
to investigate how cancer and stromal cells sense and respond to
tensile or compressive forces. And the techniques that we have
described will complement our understanding of the effects of
altered stiffness44.

Methods

Planar-cut method. Releasing solid stress. The 2% agarose was made from lowgelation temperature agarose (Sigma-Aldrich) mixed with PBS buffer. The agarose
solution was in a liquid state at 40 °C. The freshly excised tumour was first washed
with PBS and then immersed in the liquid agarose inside a custom-made aluminium cast. The cast was then cooled in ice water. After the agarose gel solidified,
the tumour–agarose construct was removed from the cast and manually cut with a
razor blade at the plane of interest. The solidified agarose that surrounded and held
the tumour allowed the tumour to be cut with minimal displacement relative to the
gel. One half of the tumour was removed from the gel and fixed in 4% formaldehyde for histological analysis; the other half, still inside the agarose construct, was
kept immersed in PBS for at least 10 min to allow the tissue to relax and deform
with the release of the solid stress and elastic energy. The same method was used
for the control tissues.
Tissue imaging and post-processing. The tissue deformation map was acquired
via high-resolution ultrasound (Vevo 2100 system; FUJIFILM Visual Sonics) on
the half of the tumour–agarose construct that was immersed and relaxed in PBS.
We used the probe MS550S for large samples such as primary breast tumours
(depth of view = 13 mm, frequency = 32–56 MHz) and the probe MS700 for smaller
samples such as brain tumours (depth of view = 9 mm, frequency = 30–70 MHz).
The high-resolution ultrasound provides a resolution of 20–30 μm. For higher
resolutions and smaller samples, optical systems such as the OFDI system29 can be
used (resolution =  1 μm, depth of view = 2–3 mm). The 3D images were exported
from VisualSonics software to MATLAB (The MathWorks) for post-processing.
The post-processing included smoothing, which was performed with moving
averaging on the top (cut plane) and bottom surfaces of the tumour to remove
any noise introduced by ultrasound imaging. The top and bottom surfaces were
exported to SolidWorks (Waltham) for 3D reconstruction of the surfaces into
a solid object. This solid object was then exported to the compatible finite-element
model, as described below.
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Mathematical modelling. In the planar-cut method, to translate the
stress-induced deformation to solid stress, we developed a mathematical
model using the general-purpose commercial finite-element software
ABAQUS (Version 6.9, SIMULIA). The 3D geometry of the tumour was
imported from the SolidWorks software as described above. We used the
element type C3D10, a quadratic tetrahedral element with two elastic parameters:
Young’s modulus and Poisson’s ratio, which were obtained as described below.
The assumptions for the use of equation (1) are justified in Supplementary Note 1.
We have shown that the viscoelastic time constant is on the order of 10 min
(Supplementary Figs 8 and 9) for the length scales comparable to tumour
diameter (this time constant is mainly determined by Young’s modulus
and hydraulic permeability in poroelastic materials45,46). In contrast,
the biological processes that give rise to solid stress in tumours, such as
proliferation, extracellular-matrix deposition and cell contraction, occur
on a timescale that ranges from several hours to several days. Since this is
much longer than the viscoelastic time constant, the equilibrium mechanical
properties that we are measuring reflect the appropriate properties in the
generation and application of solid stress.
The agarose gel was solidified from a liquid state under no external or
internal residual stress. Thus, the cut surface in the agarose gel provided the
reference plane that represented the original plane of the tumour tissue before
stress relaxation in the tumour. A displacement profile was assigned to the top
deformed surface of the tumour to translate it back to the original reference
plane. This assigned deformation was only in the direction perpendicular to the
surface of the tumour (the z direction), and the top surface of the tumour was
free to move parallel to the surface direction (the x–y plane). This displacement
assignment translates the tumour geometry from the relaxed state (deformed
surface) to the original stressed state before the cut (flat surface). The stress
component σzz generated after the displacement assignment is reported as the
solid stress in the intact tumour. For ex vivo applications of the planar-cut
method, the boundary condition on the bottom surface of the tumour was
defined as zero force. This assumption is justified for cases such as mouse models of breast tumours where the solid stress field is mainly generated internally
and the tumour is not experiencing any major external confinement or resistance. For in situ application of the planar-cut method, a contact surface was
defined between the tumour and the surrounding normal tissue. In these cases,
such as with brain tumours, the normal tissue was also modelled as an elastic
material with known Young’s modulus, obtained as described below. The solid
stress component in the direction perpendicular to the cut surface (z direction)
σzz is reported. The model also reports the elastic energy density, equivalent to
the work done to displace the deformation back to the original coordinates,
normalized by the tumour volume.
Slicing method. Releasing solid stress. The tumour was embedded in 2% agarose
gel as described in the planar-cut method, except that the solidification occurred
in a stainless steel cast provided with the commercial VF-300 compresstome
(Precisionary Instruments). The tumour–agarose construct, fully immersed
in PBS, was then sliced using the compresstome with the desired thickness in
the range of 100–500 μm. The tumour slice was detached from the agarose slice,
leaving an empty area in the agarose gel. This empty area, here called the ‘blank’,
represents the tumour area before stress relaxation by slicing. The tumour slice was
detached from the surrounding agarose manually with a pair of sharp tweezers;
detachment occurred spontaneously in some cases. The slice was kept immersed
in PBS for at least 10 min while solid stress was released. As a result of stress
relaxation, the sample slice underwent expansion in area through different
modes of bending and buckling.
Imaging and post-processing. The sample slice and the blank agarose gel were
imaged in 3D via high-resolution ultrasound (for larger tumours) or OFDI
(for small samples such as a lymph node). The surface areas of both the sample
slice and the blank were then calculated by custom in-house MATLAB codes.
The change in the ratio of the surface area after stress relaxation to the surface
area before stress relaxation (equal to the blank area) was defined as an index
of the solid stress and elastic energy.
Needle-biopsy method. Releasing solid stress. The solid stress of the tumour
was released by punching a hole with rotating biopsy punches (Integra-Miltex)
with diameters of 1.5–3 mm. The rotating punch was made by detaching the
stainless steel blade of the biopsy punch from the plastic holder and rotating it
with a Dremel rotary tool (Dremel). The rotary punch reduced cutting artefacts
by minimizing the mechanical disturbance otherwise caused by non-rotating
punching. In ex vivo cases, the sample was either held gently by tweezers or
embedded in 2% agarose to be secured during the punch. For in situ cases such
as brain tumours, we made a 2-mm-diameter hole in the plastic coverslip of the
cranial window without disturbing the underlying brain tissue. Through this hole
in the cranial window, we then punched the brain tumour with a 1.5-mm-diameter
punch. The samples were left submerged in PBS for at least 10 min, the time needed
for stress relaxation. The biopsy core, which also changed in diameter due to solid
stress, was similarly preserved in PBS.

Imaging and post-processing. The stress-induced deformation and the sample geometry
were imaged via high-resolution ultrasound as described in the planar-cut method.
Using custom in-house semi-automated MATLAB codes we calculated the area of the
biopsy hole along the punch axis, from which we calculated the mean hole diameter.
Mathematical modelling. An axisymmetric finite-element code was developed
in ABAQUS to translate the stress-induced deformation to the solid stress.
A deformation profile was assigned that transformed the deformed punch
profile to the original profile before stress relaxation. The original hole profile was
simply determined by the biopsy punch diameter, which was uniform along the
hole axis (the z axis) and equal to 1.5 mm for small samples such as brain tumours
and 2–3 mm for larger samples. In the ex vivo cases, a zero-force boundary
condition was prescribed at the outer surface of the tumour to simulate the
physiological conditions. For in situ cases, a contact surface was defined between
the tumour and the normal tissue, such as brain, with known elastic properties.
We used the four-node axisymmetric element CAX4R for both the tumour and
the surrounding tissue. The material properties of both the tumour and the
surrounding tissue were obtained via micro and macro measurements of the
stiffness, as described below. The stress σrr, the component of the solid stress
on the cut surface, in the direction perpendicular to the axis of the hole
(z direction), is reported. The mathematical model also reports the elastic
energy density, equivalent to the work done to displace the deformation back
to the original coordinates, normalized by the volume of the tumour.
Micro and macro measurement of tumour stiffness. The stiffness of the
tumours was measured using AFM on the microscale as the indentation
modulus, and on the macroscale as the unconfined compression modulus.
For both cases, the measurement was obtained within 1 h after excision
of the tumours. The samples were maintained in PBS with protease inhibitors
(Complete Protease cocktail tablets, Roche Applied Science) at 4 °C before
testing. All of the measurements were performed in near-physiological PBS
at ambient temperature (25 °C).
AFM-based measurement of the indentation modulus. The indentation moduli
of tumours were quantified using an Asylum MFP3D AFM (Asylum). We used
polystyrene colloidal probe tips with an end radius (R) of ~12.5 μm (Polysciences)
attached to tipless cantilevers with nominal spring constant k ~ 0.12 N m–1
(Bruker). The colloidal probes were attached to the cantilever by the lift-off
process: a dot of glue (M-Bond 610, Structure Probes/SPI Supplies) was placed on a
tipless cantilever by making quick contact between the cantilever and a thin layer
of glue (1 μl thick) spread over a 10 mm × 10 mm mica surface. We then made
immediate contact between the tip of the cantilever and a colloid probe resting
on a glass slide and waited for 1 min with the cantilever pushing against the colloid.
This process was followed by heat curing for 2 h at 150 °C. For each probe tip, the
exact spring constants of the cantilevers were directly measured using the thermal
calibration method47. The relationship between the detected voltage and the applied
force was calibrated by bringing the cantilever into contact with a glass slide and
calculating the slope of the voltage–displacement curve. The displacement, d, was
translated to force, F, using Hooke’s law (F =  kd). The indentation was performed
under a force control scheme (maximum force ~20 nN) limiting the indentation
depths to 0.5–3 μm. The tip displacement was obtained by subtracting the
cantilever deflection from the vertical movement of the piezoelectric actuator.
An indentation approach velocity of 2 μm s–1 ensured that the elastic modulus was
probed at a lower rate, close to equilibrium conditions.
The effective indentation modulus Eind was computed using Hertzian contact
mechanics models via least-squares linear regression of the experimental loading
force–displacement curves. For the spherical colloidal probe tip with end radius R
on the sample with thickness h ≫ R (here, h ~ 5 mm, R ~ 12.5 μm)
F=

4 E ind 1/2 3/2
R D
3 (1 − v 2)

where F is the indentation force and D is the indentation depth (we assumed
v  = 0.1, as measured in other soft tissues48,49). A representative force–displacement
curve is shown in Supplementary Fig. 10.
Macroscale unconfined compression test. Young’s moduli of tumours were
determined by unconfined compression tests50. Slices of freshly excised tissue,
3 mm in diameter and ~2 mm thick, were placed in an unconfined compression
chamber submerged in PBS. The chamber was mounted in an ultrasensitive
servo-controlled materials tester (Dynastat Mechanical Spectrometer; IMASS).
Each specimen was compressed by 5% of the original height in ramps of 20 s and
allowed to relax for 20 min. Four successive measurements were performed with
each tissue slice. Young’s modulus was determined as the ratio of the linear fit to
stress–strain data (Supplementary Fig. 8).
Cell culture. Cells (MMTV-M3C, AK4.4, SL4, U87, 4T1) were cultured
in DMEM (ATCC 30-2002) medium containing 10% fetal bovine serum.
Cells were harvested at ~80% confluency, washed twice with PBS, counted and
re-suspended in DMEM before injection. All cell lines repeatedly tested
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negative for mycoplasma using the Mycoalert Plus Mycoplasma Detection Kit
(Lonza), authenticated before use by IDEXX laboratories.

Code availability. Custom scripts for MATLAB are available in the Supplementary
Information.

Tumour models. Primary tumour models. MMTV-M3C cells (Her2+) were
provided by P. Huang (Massachusetts General Hospital, Boston, Massachusetts,
USA) and were isolated from lung metastases of mammary adenocarcinomas in
mice generating spontaneous mammary tumours (MMTV-PyVT). Orthotopic
breast tumours were generated by implanting a small piece (1 mm3) of viable
tumour tissue (from a source tumour in a separate animal) or by injection
of 1 ×  105 cells into the mammary fat pad of a 6- to 8-week-old female FVB
mouse (MMTV-M3C). AK4.4 cells (KrasG12D and p53+/−) were provided
by N. Bardeesy (Massachusetts General Hospital, Boston, Massachusetts,
USA) and were isolated from mice generating spontaneous pancreatic tumours
(Ptf1-Cre/LSL-KrasG12D/p53Lox/+). Orthotopic pancreatic tumours were similarly
generated by implanting a small piece (1 mm3) of viable tumour tissue into the
pancreas of a 6- to 8-week-old male FVB mouse (AK4.4 model). The SL4 mouse
colorectal cancer cells were provided by T. Irimura51. For the orthotopic SL4 model,
5 ×  105 cells in 10 μl of PBS and extracellular-matrix-rich gel (Corning Matrigel)
were injected into the caecal wall between the serosa and mucosa from the serosa
side using an insulin syringe with a 27G needle. For the glioblastoma model, cranial
windows were implanted into nude mice as previously described52, and the mice
were allowed to recover for 1 week before tumour implantation. U87 fragments
(0.2–0.3 mm in diameter; from a source tumour in a separate animal) were
implanted into the left cerebral hemisphere 0.5–1 mm deep in 6- to 8-week-old
female nude mice. All animal procedures were carried out following the
Public Health Service Policy on Humane Care of Laboratory Animals and
were approved by the Institutional Animal Care and Use Committee of
Massachusetts General Hospital.

Data availability. Source data for the figures in this study are available in figshare
with the identifier https://dx.doi.org/10.6084/m9.figshare.3796092 (ref. 53). The
authors declare that all other data supporting the findings of this study are available
within the paper and its Supplementary Information.

Liver metastasis model. Mice were anaesthetized with an intraperitoneal injection
of ketamine (100 mg per kg) and xylazine (10 mg per kg). A left-flank incision
was made through the skin and abdominal wall, and the spleen was exteriorized.
The middle of the spleen was ligated with a suture before transection, with
the goal of preserving the vascular pedicles to both hemispleens. 1 ×  105 cells
(AK4.4 or SL4) in 100 μl DMEM were injected slowly into the distal lobe
with a 30G needle. After 10 min, the hemispleen used for tumour cell injection
was resected. The remaining spleen was placed back into the abdomen.
The abdominal wall was closed with a continuous suture. The skin was closed
with surgical staples.
Lymph node spontaneous metastasis. 2 ×  105 4T1 cells in DMEM were injected into
the second mammary fat pad of syngeneic BALB/c mice. On day 15 post-injection,
the primary tumour was resected. Animals were killed 2–3 weeks post-resection
to evaluate the metastatic lymph nodes.
Histology. Before death, mice were slowly (~2 min) injected with 100 ml
of 1 mg per ml fluorescein isothiocyanate (FITC)-conjugated lectin (Vector Labs)
via the tail vein 5 min before tumour removal, long enough for FITC-lectin to
reach perfused vessels. The tumours were then excised, fixed in 4% formaldehyde
in PBS overnight and embedded in paraffin blocks. Transverse tumour sections,
5 μm thick, were immunostained with antibodies for endothelial marker CD31
(DIA310, Dianova, 1:100 dilution) and counterstained with DAPI (Vector Labs).
Collagen I and hyaluronan were, respectively, detected using the LF-68 antibody
(1:500 dilution) provided by Larry Fisher (NIDCR) and a biotinylated hyaluronan
proteoglycan fragment (385911, Calbiochem). For the detection of collagen I, the
paraffin-embedded sections were treated with a pH-9.0 trypsin antigen-retrieval
solution and counterstained with DAPI. Staining for aSMA (C6198 antibody,
Sigma, 1:100 dilution) was also carried out. The entire tumour section at
×10 magnification was taken from each slide using a confocal microscope
(Olympus) or slide scanner (TissueFAXS). For vascular analysis, vessels were
segmented using a custom semi-automated tracing program developed in
MATLAB, allowing the analysis of each vessel according to its size and
staining intensity. Tumour perfusion was assessed by identifying the fraction
of CD31+vessels that were also positive for FITC-lectin, indicating that those
individual vessels were perfused before the mice were killed, and are therefore
functional and uncompressed.
Collagenase treatment. The collagenase (Sigma-Aldrich) solution was prepared
by dissolving 10 mg collagenase in 10 ml DMEM. After excision, the tumour was
placed in the collagenase solution remaining at 37 °C for 2 h before solid stress
measurement.
Statistical analysis. The data are presented as the mean ± standard error of the
mean. Groups were compared using an unpaired two-sided Student’s t-test
(due to independent sampling) with equal or unequal variance. The variance
similarity was tested via F-test with P = 0.05. All of the results are based on pilot
studies (not reported) preceding the main experiments (reported). The sample
size for the main experiments were determined from the pilot studies. Mice were
size-matched as appropriate for each experiment. No additional blinding or
randomization was required for the animal studies.
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